Helix Acquisition Corp. II Class A Ordinary Shares (HLXB) Dividend History

Helix Acquisition Corp. II is a special purpose acquisition company (SPAC) that was formed to identify and acquire a target company in the healthcare, biotechnology, or life sciences sectors. As a blank check company, it raises capital through an initial public offering with the intention of merging with or acquiring an existing company to facilitate its growth and public market listing.

C/O Cormorant Asset Management, Lp, Boston, MA, 02116
Phone: 857 702 0377

Dividend History

Helix Acquisition Corp. II Class A Ordinary Shares currently does not pay dividends

Company News

Helix Acquisition Corp. II Retains More than 60% of Trust Account after Redemptions in connection with Business Combination with BridgeBio Oncology Therapeutics

Helix Acquisition Corp. II announced retaining approximately $120 million in its trust account, representing over 60% of cash, in connection with a business combination with BridgeBio Oncology Therapeutics. The transaction is expected to raise $382 million in gross proceeds, including $261 million from a private placement.

Benzinga

Featured Companies: BBIO

Page data last updated 08/19/2025 16:54:08 UTC